Our mission is to provide leadership to prevent disability, build resilience in individuals and their communities and facilitate recovery for people affected by mental illness, substance abuse or intellectual or developmental disability. Please
visit the DBHDID website for additional information.
Administrative Regulations Notice
Aug. 4, 2022
The Department for Behavioral Health, Developmental and Intellectual Disabilities filed the following proposed administrative regulation amendments Aug. 4, 2022. View the amendments on the Legislative Research Commission website.
908 KAR 1:374 Licensure of nonhospital-based outpatient alcohol and other drug treatment entities
Summary: The regulation amendment establishes standards for nonhospital-based alcohol and other drug treatment entities providing ambulatory withdrawal management, outpatient treatment services, intensive outpatient services, partial hospitalization or office-based opiate treatment services. It further establishes standards for operation of narcotic treatment programs in accordance with KRS 222.231(12) and 42 C.F.R. Part 8 and updates federal standards in compliance with Senate Bill 178 (2022 Regular Session).
Written public comments may be submitted to the Office of Regulatory Affairs through Oct. 31, 2022. Upon request to the Office of Regulatory Affairs by Oct. 17, 2022 a public hearing will be held Oct. 24, 2022, at 9 a.m. via Zoom.
Feb. 22, 2022
The Department for Behavioral Health, Developmental and Intellectual disabilities filed the following proposed administrative regulation amendments Feb. 21, 2022. View the amendments on the
Legislative Research Commission website.
908 KAR 3:010 E and O - Patient's rights
Summary: This amended emergency administrative regulation incorporates the designation of an essential personal care visitor, as defined and established in SB 100, for a resident of an assisted-living community, long-term care facility or state-owned or -operated psychiatric hospital. The ordinary amended administrative regulation is identical to the above-referenced regulation.
Written public comments on the emergency version may be submitted to the
Office of Regulatory Affairs through April 30, 2022. Upon request to the
Office of Regulatory Affairs by Apr. 21, 2022 a public hearing will be held Apr. 28, 2022, at 9 a.m. via Zoom.
Written public comments on the identical ordinary version may be submitted to the
Office of Regulatory Affairs through May 31, 2022. Upon request to the
Office of Regulatory Affairs by May 16, 2022 a public hearing will be held May 23, 2022, at 9 a.m. via Zoom.